Other notable approvals for individuals with rare diseases consist of, one) a different drug to treat sure sufferers with Hutchinson-Gilford Progeria Syndrome and progeroid laminopathies, rare problems caused by selected genetic mutations that bring on premature ageing, and, 2) a new drug for that treatment of thyroid eye disease, a rare situation